2006
DOI: 10.1007/s00464-005-0594-7
|View full text |Cite
|
Sign up to set email alerts
|

Palliative stent implantation in the treatment of malignant colorectal obstruction

Abstract: For palliative treatment of malignancy-induced colorectal obstruction, SEMS is an efficient tool associated with low morbidity and minimal mortality. From a technical point of view, all tumor locations are accessible.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
42
0
4

Year Published

2008
2008
2015
2015

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 64 publications
(51 citation statements)
references
References 30 publications
5
42
0
4
Order By: Relevance
“…The authors concluded that the high perforation rate could be either specifically WallFlex-related or enteral-stent-related in patients on chemotherapy. In contrast, one study conducted in the same year as the previously cited randomised trial and using the WallFlex stent was associated with a perforation rate below 5% (19), which is in line with previous studies using other stents (11,14,20). The results of prospective trials and of recent retrospective studies further demonstrated the effectiveness of SEMS in the palliative management of malignant colorectal obstruction (6,7,(12)(13)(14)21).…”
Section: Discussionsupporting
confidence: 82%
See 1 more Smart Citation
“…The authors concluded that the high perforation rate could be either specifically WallFlex-related or enteral-stent-related in patients on chemotherapy. In contrast, one study conducted in the same year as the previously cited randomised trial and using the WallFlex stent was associated with a perforation rate below 5% (19), which is in line with previous studies using other stents (11,14,20). The results of prospective trials and of recent retrospective studies further demonstrated the effectiveness of SEMS in the palliative management of malignant colorectal obstruction (6,7,(12)(13)(14)21).…”
Section: Discussionsupporting
confidence: 82%
“…These results, however, conflict with other studies reporting short-and longterm clinical failure in more than 50% of patients, along with a high number of severe complications (4,5). Furthermore, several risk factors have been associated with stent patency, complications and clinical outcomes, as well as with conflicting results (1,6,(12)(13)(14). The question remains: are SEMS used for definitive palliation of malignant colorectal obstruction as successful as those used as a bridge to surgery?…”
Section: Introductionmentioning
confidence: 92%
“…Она развивается у 26,4-69,0% па-циентов [10][11][12]. Наиболее характерно это ослож-нение для опухолей левых отделов толстой кишки (67-72%), что связано с особенностями местного роста рака этой локализации (эндофитный, цир-кулярный), спецификой интрамурального лимфо-оттока, а также большей плотностью опухоли этой локализации и меньшим диаметром кишки [13][14][15][16][17].…”
Section: актуальность проблемыunclassified
“…In palliative settings, SEMS also significantly reduce the chance of stoma creation, length of hospital stay, mortality rate, and medical complications compared with palliative surgery [1, [13][14][15]. Additionally, it allows these patients to enjoy the full benefits of minimally invasive surgery [16].…”
mentioning
confidence: 99%
“…It is a common cause of delayed recurrent obstruction following apparently successful initial SEMS implantation, especially with the use of uncovered stents [10,21]. Prospective studies and systemic reviews showed that the time for colonic reobstruction ranged from 48 hours to 480 days after stent placement [6,13,14,21]. This variation in stent patency duration may be due to difference in demographic factors, underlying malignancies, or types of stents used [6,14].…”
mentioning
confidence: 99%